Emphysema

December 5, 2014December 5, 2014

Researchers Uncover Unique Genetic Features Related to Emphysema

Emphysema

A new study entitled “Genes related to emphysema are enriched for ubiquitination pathways” published in BMC Pulmonary Medicine, aimed to determine the potential relationship between gene expression and specific phenotypes ... Read more

November 5, 2014November 5, 2014

Diabetes More Prevalent in COPD Patients Without Emphysema

Emphysema, News

In a new study entitled “Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus” published in BMC Pulmonary Medicine the authors suggest chronic obstructive pulmonary disease without emphysema is ... Read more

October 14, 2014

New Stem Cell Research Offers Insights Into Novel Emphysema Therapies

Emphysema, News

A new study entitled “Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema” published in Respiratory Research, studied the impact of different mesenchymal stem (stromal) cells ... Read more

October 6, 2014November 6, 2015

Protein Signatures Found in Lung Disease Patients with Dyspnea

Asthma, Emphysema, News

A means to detect dyspnea, or shortness of breath, using proteins and microRNA would allow afflicted individuals to seek the care they need before greater problems emerge. A study conducted ... Read more

August 26, 2014August 26, 2014

Prior Cases of Chronic Bronchitis, Emphysema Found To Elevate Risk for Lung Cancer

Chronic Bronchitis, Emphysema, Lung Cancer, News

A team of researchers from the International Agency for Research on Cancer, Lyon, France, has found that individuals who were previously diagnosed with chronic bronchitis or emphysema are at higher ... Read more

May 30, 2014November 11, 2015

GSK’s Incruse Ellipta Approved By FDA For Treating Chronic Bronchitis, Emphysema, COPD

Chronic Bronchitis, COPD, Emphysema, News

The U.S. Food and Drug Administration (FDA) recently authorized Incruse Ellipta for the treatment of airflow obstruction in patients who suffer from chronic obstructive pulmonary disease (COPD), as well as ... Read more

May 20, 2014May 20, 2014

Kamada Reports Preliminary Results from Phase II/III Pivotal Trial in Europe and Canada of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency

Emphysema, News

Ness Ziona, Israel, based plasma-derived protein therapeutics company Kamada Ltd. this week announced preliminary top-line results from its recently completed Phase II/III pivotal clinical trial in Europe and Canada of ... Read more